Cassidy Says Obamacare Repeal Will Not Repeal Biosimilars Approval Pathway
By Zachary Brennan -
Published 07 December 2016
Sen. Bill Cassidy (R-LA) told attendees of a policy briefing at the Newseum on Wednesday that when Republicans repeal Obamacare, which is expected to occur soon after President-elect Donald Trump takes office, the approval pathway for biosimilars that was created thanks to that law will not go away.
Categories: News, US, FDA, Biologics and biotechnology, Business and Leadership, Government affairs, Regulatory intelligence, Regulatory strategy
Tags: Obamacare, ACA, biosimilars, Bill Cassidy